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Abstract. From the beginnings of the biochemistry as discipline, the dichotomy between in
vivo- in vitro conditions has been in the center of their methodological discussions. With the
growing influence of computer simulations - sometimes called "in silico" conditions-, a new
methodological problem is added to biochemistry. However, "simulation" could be seen as a
core concept that is in fact used in the in vivo - in vitro dichotomy. In this sense, in silico
dimension could be considered as a natural extension of the classical dichotomy. From the
way in which simulation is used on in vivo-in vitro dichotomy, we also suggest that the
general idea of simulation proposed by Hartmann have to be redefined. The intuitive idea of
simulation resting on “imitation” relationship, as a “process that imitates another process”
(Hartmann 1996), has to be complemented by others methodological concepts like
“isolation” or “disruption”.
Introduction
From the beginnings of the biochemistry as discipline, methodological considerations
have been in the center of their discussions. Among these methodological considerations, one
of the most important has been the tension between in vivo and in vitro conditions. How to
evaluate and refine these conditions has been a central challenge of biochemistry. Significant
methodological advances in biochemistry have been motivated in the necessity of achieving
more reliability for in vivo and in vitro experiments. With the growing influence of computer
2simulations, a new condition- sometimes called in silico- comes into biochemistry. It is natural
to assume that, with this condition, new methodological problems appear. However, beside
some particular problems derived from new methodologies, ‘simulation’ could be seen as a core
concept that is actually used on in vivo - in vitro dichotomy. This use is consistent with a
general concept of simulation proposed by Hartmann. According to Hartmann, a simulation is a
“process that imitates another process” (Hartmann 1996). Despite this initial agreement, we will
argue that, if we take into account biochemical practices, Hartmann’s simulation idea has to be
complemented by others concepts beyond “imitation” relationship, like “disruption” or
“isolation”.
In the section I of the paper, we will trace some sources of simulation idea in
biochemistry. In this section, we will also start to show how biochemists use of simulation idea
is to some extent different from Hartmann’s proposal. In section II, we will continue this
discussion in the context of computer simulation in biochemistry. In this section, we will argue
that we can make, in biochemical computer simulations context, a similar statement about
simulation concept modification.
I. Simulation in biochemistry
The concept of simulation has been used by biochemists long time before computers
arrived1. Expressions like “in vitro simulation” or “in vivo simulation” are commonly used in
experimental contexts (Bugnon et al. 1998). This use is based on the methodological concern of
getting reliable experimental conditions. A ‘reliable’ experimental condition is usually understood
in this context as a situation that resembles, in some aspects, another one. In this sense, we
1 We suggest here only that biochemists have been used simulation concept, not that they have been used this particular term or
expression.
3can think that simulation idea could rest on “imitation” relationship. This first intuition could be
traced from historical origins of biochemistry.
Biochemistry uses several methodological concepts from chemistry. Among them,
“isolation” and “purity” are pointed out by historians as central (Fruton 1972). The ideal in this
case was “to isolate” a substance or compound and, in this way, be able to study this substance
or compound in its “pure” state. This common chemical methodology was called later “in vitro”
when it was adopted by biochemistry, because it was understood as related with conditions of a
living organism or process – in vivo conditions-. This in vitro approach could be considered a
consequence of a “mechanistic” and “antivitalistic” position (Kohler 1973). Physiologists
assumed that vitalistic ideas were wrong, and then they expected that in vitro conditions
gradually substitute any vestige of in vivo conditions. It was supposed that a particular
compound or pathway, separated from its “vital” context, could conserve their properties or
main behavior. Therefore, this supposition was operating every time in vitro results were
related with in vivo conditions. But, shortly those suppositions exhibit their limits, specially when
physiologist compared in vitro outcomes with results from alive organisms. Because, an
“analytical” approach produces imprecise results, biochemists tried to ‘imitate’ some especially
complex processes. For example, by the middle of XIX century, physiologists started to develop
a technique called “perfusion”, that later became widely used in intermediary metabolism
studies (Holmes 1991). In this method an organ was maintain in physiological conditions that
are close to an organism alive by pumping blood to a particular organ. This way, biochemists
tried to ‘imitate’ vital conditions in order to obtain better experimental results.
This brief description seems to fit well with a general idea of simulation proposed by
Hartmann (1996), who define simulation in terms of "imitation" and "process". A simulation is
then "a process that imitates another process" (p.83). Indeed, simulation could be seen as class
4of model -a dynamic model-. When a simulation is carry out by a computer, it is called a
"computer simulation". This general point of view is followed by Humphreys when he tries to
characterize computer's simulations (Humphreys 2004). Beside this last consideration, we can
see Hartmann’s simulation concept as a general characterization that includes not only
computer programs but also scientific practices. However, when we inspect scientific practices
to see how is understood the relationship between in vivo- in vitro we realize that the
"imitation" part of simulation idea have to be complement by others concepts. To develop this
suggestion, we have to come back to perfusion example.
Perfusion techniques for intermediary metabolism research were widely used until the
beginning of the XIX century. Some important knowledge about intermediary metabolism was
acquired. However, persistently failures in this biochemical area started to show the limits of
this technique (Holmes 1991). Those failures produce two main consequences. First, the
growing awareness of the complexity of biochemical field research. Second, the necessity of
changing an input-output schema in order to get reliable results in intermediate metabolism
studies (Fruton 1999:360-361). Moreover, it was not clear that perfusion could be the technique
that allows this change. By using perfusion technique in intermediate metabolism, physiologist
could determine in a quantitative way “the overall rates of metabolism, the relative proportions
of carbohydrates, fat, and protein metabolized” (Holmes 1992:152) among others things.
However, as Holmes has point out, perfusion technique was unable to detect the intermediate
stages of a metabolic process, because the intermediate metabolites were produced in small
quantities. A new technique or methodological tool was needed. Otto Warburg developed a
method that allowed conserving tissues in such a way that similar results to perfusion method
could be obtained but with a better observational capacity. This technique depended on the
possibility of cutting the tissues "slices" between certain limit: around 0.2 mm in ordinary air
5and 0.5 mm in pure oxygen (Holmes 1991:163). Metabolic reactions in those tissues slices were
later measured with an instrument called micromanometer, also developed by Warburg.
This schematic history from perfusion to slides tissues techniques could be seen as a
successful account for in vitro methods. However, it could be seen also as a sophistication of
the classical dichotomy. Tissues slide methods could be understood as a more precise technique
that suppose an in vivo approach. This technique was originally developed by Warburg for study
some hypothesis about the mechanism of cancer. By 1931, Krebs, a former Warburg’s
collaborator, started to apply this technique to intermediate metabolism. But, it was considered
problematic to apply this technique, because it was believed, or at least supposed, that there is
had to be a link between the structure of the cell and metabolic process. Because the tissue
slices technique depends on cutting the cells, biochemists like Warburg did not trust in this
technique. It is controversial if this supposition is a vestige of vitalistic ideas, but it show
anyway the profound concern about simulation of in vivo conditions. Of course, Krebs spend
several weeks testing how accurate and reliable tissue slice technique could be – by replicating
well know experiments in intermediary metabolism-. This way Krebs could establish tissue slice
technique and micromanometer as a reliable simulation of in vivo conditions.
Nevertheless, the better simulation approach representing by tissue slices technique
compared with perfusion technique is not resting only on an imitation relationship, but in a sort
of isolation or disruption relationship. Cutting tissues and putting them in a glass container were
considered a very artificial way to study metabolic reactions. But, this kind of technique do not
represent a triumph of in vitro approach, as we could suppose. Their design and use was
motivated by the goal of achieving a better in vivo description. In this sense, we can see
biochemical simulation concept- consisted on imitation and disruption relationship - as a
consequence of in vivo-in vitro tension. In fact, tissues slide technique resembles less than
6perfusion technique, but it simulates better. Therefore, it could be said that this result is
partially allowed by isolation.
This intuition is present in Roger Strand characterization of in vivo- in vitro relationship.
Strand tried to carry out a characterization of the in vivo- in vitro relationship from a perspective
near to the biochemical practices (Strand, Fjelland, Flatmark, 1996). When he describes in vitro
studies he point out that they have to be different from in vivo “in order to overcome the in vivo
methodological problems” (p. 2). An in vitro study consisted on a simulated situation, in an
artificial way, of a “target phenomena”. When the “target phenomena” is supposed to be so
complex or unknown that the in vitro result became unreliable, then another kind of simulation
is carried out: in vivo studies. In vivo studies use an organism or process that is close or similar
to the target phenomena. In general, an experiment is called “in vivo” when is carried out in
animals alive. The majority of in vivo and in vitro simulations try to prevail over some
methodological limitations2. This prevailing is only possible because some complex phenomena
are sometimes “simplified”, “isolated” or “disrupted” from his original context. Therefore,
simulation idea, in a biochemical context, could be seen, at least, as a two-folded concept, as
long as “imitation” and some kind of “isolation” relationships are needed.
It is important to stress that in vivo and in vitro condition does not always work like
model and target phenomenon, because both conditions can be seen as simulations. In
biochemical practices, in vivo conditions are used in different ways. When an in vivo experiment
or simulation is carrying out, the target phenomenon could be another in vivo process or an in
vitro experiment. The target phenomenon depends on the experimenter goals. For this reason,
2 Of course, in vitro simulations are sometimes used to overcome ethical problems, but here we want to
stress only the methodological role of simulations.
7when we refer to in vivo or in vitro conditions, we have to be aware that their function is case-
dependent. Anyway, we can say that in the majority of biochemical experimental contexts, the
in vivo-in vitro dichotomy is working.
II. Biochemical computer simulations
In the previous section, we have suggest some extensions to simulation concept, at
least when it is applied to biochemical practice. But, if this extension of simulation concept rest
mainly on some biochemical practices, it is not directly evident that it could be applied to
computer simulations in biochemistry. Therefore, in this section we try to show how the
extension of simulation concept could be also used to understand computer approaches in
biochemistry. In order to achieve this goal, we are going to discuss some particular examples
that belong to the same area than the examples discussed in the previous section.
Computer simulations are now widely used for study metabolic reactions. Some
computer approaches are more concern with abstract aspects of biochemical kinetics
(Haunschild, Freisleben et al. 2005) or with general aspects of the cell (Tomita, Hashimoto et al.
1999). Others computer approaches are more concern with particular aspects of metabolic
process. In this last group, there are programs like METAMOD, Gepasi3 or Scamp that tries to
simulate different aspects of biochemical reaction dynamics. This type of computer program can
be considered as an aid in model building and testing, because one of their main tasks is to
translate biochemical formulas into mathematical equations.
For example, the user of Gepasi program has to supplies the system with information
about stoichiometric structure of the pathway, kinetics of the reactions that are to be
considered and the initial concentration of chemical species. Then Gepasi build the differential
3 The entire project behind Gepasi has been recently reformulated by Pedro Mendes with a program for simulating biochemical
networks called Copasi -COmplex PAthway Simulator-. (More information could be found at http://www.copasi.org)
8equations that characterize the system. This way Gepasi could describe the temporal evolution
of reactions. Gepasi is also generally used to study steady-state properties of pathways. In
particular, this program has been used to study enzymes interaction in biochemical pathways.
The others programs cited above are used in similar contexts than Gepasi. METAMOD is
a software package for study steady-state metabolic pathways. This package allows also study
control analysis of metabolic pathways. Scamp is a general-purpose simulator of metabolic
reaction.
We are going to analyze a couple of examples about how this kind of computer program
is used by biochemists. Those follow examples rest mainly on studies about metabolic
channelling and drug design made by Cornish-Bowden and collaborators (Cf. Cornish-Bowden
1991 and Cornish-Bowden 2003).
There has been a discussion in biochemical literature about the in vivo function of a
special interaction between enzymes called “metabolic channelling” (Mendes, Kell et al. 1996).
This kind of enzyme interaction occurs when a common intermediate between two consecutives
enzymes is directly transferred from the catalytic influence of the first enzyme to the “catalytic
center” of another enzyme (Milani, Pesce et al. 2003). When a multi-enzyme complex is in
favorable physiological conditions, there is the possibility that the product of the reaction
catalyzed by one enzyme passed directly to the next reaction as a substrate of the next
enzyme. Certainly, it is not enough to show the possibility that this metabolic channelling take
place. In this point, we can notice how in vivo- in vitro tension is working. Even if we can prove
that channelling occurs in vitro, it is not follow that this process will be happened in vivo. A way
in which we can approach to this problem is by asking about the value for the organism of the
supposing channelling. Then we can propose different hypotheses about this state of affairs.
9The next step is to build models to describe alternative situations suggested by the hypotheses.
By means of computer simulation, those models can be build and tested.
Cornish-Bowden investigate different hypothesis about metabolic channelling using
computer models (Cornish-Bowden 1991)4. In particular, he tries to test a common assumption
about metabolic channelling. It is usual to suppose that channelling decrease free concentration
of intermediate metabolites. Cornish-Bowden examines this assumption by simulating the
behavior of a set of four enzyme-catalyzed reactions. Let considering a fixed concentration of
the starting material and the intermediary metabolites. It can also be supposed that the
concentration of one of the intermediaries is too high. It is supposed that the concentration of
this metabolite could be a risk for the health of the organism, but the values of the flux and the
others metabolites are considered adequate for the needs of the organism. The problem is,
then, how to decrease the concentration of this metabolite – keeping the original values of
initial concentration and the steady-state flux -. The coefficients of the all metabolites and the
flux used in this simulation are arbitraries, but they are consistently employed in all the
simulation process (p.104).
An obvious way to solve this task is bypassing the “problematic” intermediary with a
channelling. In a model where all others parameters remain unchanged– initial material and the
kinetic of the reactions-, it is found by simulation that the concentration decreasing in the
problematic intermediary is very slight. So “it is obvious that introducing a channel into a model
without making any other changes to it does not provide a mechanism for decreasing the
concentration of the by-passed intermediate” (p.105).
4 For this particular research, it is used METAMOD (Cornish-Bowden 1991). But, the same results could be obtained with
Gepasi.
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Cornish-Bowden’s conclusion have been questioned by Pedro Mendes en several articles.
Mendes showed how channelling process could decrease free metabolites concentration by
means of some parameters variation. Then, the discussion has been centered on the legitimacy
of changing parameters in biochemical simulations. But, in any case, from those simulations is
clear that changing parameters in the model could affect the reversibility of channelling
reaction. And reversibility of channelling could be a good explanation why concentration do not
decrease, because a reversible reaction could “inhibit the ability of any channel to decrease a
pool”5 (Mendes 1992:259).
Through the simulation of different models, it is possible to test hypotheses about
channelling mechanism. But, in any case suppositions that imply considerations about in vivo
conditions are present. For example, failures in in vitro experiments seem to suggest that
channelling of dynamics complexes are related with a in vivo property of the cell6. A hypothesis
to explain this failure could be that stabilization of dynamics complexes are bound to the “intact
cells” (Mendes 1994:16). It is interesting to notice, that we found in this case a similar concern
about cell integrity, than the expressed in the case of tissue slices technique. That similarity
reveals an analogous preoccupation about in vivo conditions. It is obvious that a reliable
computer simulation has to consider this knowledge.
The other example that we take into account, involves testing models for gycolysis of
Trypanosome brucei in the context of drug design (Cornish-Bowden 2003). The Trypanosome
brucei is a parasitic protozoan that causes African sleeping sickness. This organism has a very
simple metabolism. It has not a tricarboxylate cycle (TCA), so it excretes pyruvate directly on
the host. Because this organism does not have TCA, with a glycolysis description we can almost
5 ‘Pool’ is a name used to refer to the intermediate metabolism concentration.
6 Channelling could occur in static complexes of enzymes or in dynamic complexes. The term ‘dynamic’ in this last case came
from the short life of enzymes in the complexes (Mendes 1994: 12-13).
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exhaust all its metabolic activity (p. 513). In addition, there are detailed experimental studies
about the kinetics and the enzyme parameters values of this organism. In this sense, it can be
avoided an arbitrary determination of model’s parameters. As we have seen in the previous
example, this arbitrary determination could be a source of disagreement.
One kind of problem in drug design is to identify satisfactory targets that can modify
reaction’s metabolism. Because the target in this case involves a way to kill or at least to alter
significantly the trypanosome brucei, a desirable goal could be to change the metabolism of this
organelle. A way in which metabolism can be changed is by increasing fluxes. However,
increasing metabolic fluxes is very difficult. Decreasing them could be better, but it is still
difficult. A better place to look for is metabolite concentration because there are less stable than
fluxes. In fact, alter metabolite concentrations is the mechanism working in some herbicides
and antimalarial drugs (p. 510). This mechanism supposes inhibiting enzymes. We can consider
two main inhibition types: competitive and uncompetitive7. A competitive inhibition is working
when an inhibitor and the substrate compete for the same site and their influence in the flux,
when the concentration of metabolites is not fixed, is in general very slight. On the contrary,
when we have an uncompetitive inhibition in those conditions, their influence in the flux is
important. Variations in concentrations of substrate have a very different effect when we
consider a competitive or an uncompetitive inhibitor. In the first case, variations in
concentration of substrate “nullified” the inhibitor while in the case of uncompetitive inhibitor
those variations “potentiate” the inhibitor (p. 511).
From the previous considerations, a potential target of drug design could be a reaction
that involves an uncompetitive inhibition. “Stoichiometric constrains” on metabolite
7 There are other main types like reversibles or irreversibles inhibitions and there is also a division between noncompetitive and
uncompetitive inhibitions. But, here we are only concern with competitive and uncompetitive inhibitions (Cf. Leskovac
2003:73ss).
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concentration, select only four – of many- targets as useful8. In addition, one of this targets is
not “intuitive obvious” for a biochemist. This particular target is the pyruvate transporter in the
Glycolysis of trypanosome brucei9 (pp. 513-514). By selecting pyruvate transporter as an
available target, a successful computer simulation has been accomplished.
Those cases are examples of computer simulations in biochemistry. How are they
related with simulations in biochemical practices developed in the previous section?. Is there a
significant difference between the way in which simulation idea is used in biochemical practices
and in computational programs?. Both questions can be addressed together.
However, there is a previous methodological problem. Where to look for the answer to
those questions?. We can distinguish- at least- between a computational and a theoretical
model or between restrictions that are due to computational aspects or biochemical aspects of
the simulation. By setting the problem in this way, it seems that it is not difficult to make a
sharp and clear distinction between both kinds of models. For example, in a program like
Gepasi, we can separate mathematical methods used to solve the equations from the
biochemical data provided by the user. An additional intuition related with this point can
reinforce the separation between models. The mathematical methods used by programs like
Gepasi are very common and widely used in several scientific areas10. Furthermore, the
computational model could correspond to general aspect of the simulation while biochemical
model could represent particular and specific aspects of simulation. This way, we have to look
for the characterization of computational simulation only in the first group. However, it seems
8 According to Cornish-Bowden, those “stoichiometric constrains” rest mainly on “algebra”, because he uses Gaussian
elimination to analyze networks that represent stoichiometric relationship (Cornish-Bowden 2002).
9 This target is also interesting because some experimental observation had shown that inhibiting it in vivo bring about a
concentration rise.
10 This particular consideration can be understood by appealing to Humprheys’ templates concept. (Cf.. Humphreys 2004).
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that this strategy could have, as a consequence, a basic misunderstanding of computer
simulations in biochemistry.
It could be argued that what we call a computer simulation in biochemistry includes the
“pure” computational model and the theoretical or biochemical model. It is clear that this
statement is not enough. However, what is implicit in the previous statement could be
considered a deeply reason: there are some biochemical restrictions, which are not only part of
the data provided by the user but also part of the computer program construction. We do not
want to imply that a sharp separation between computational and biochemical model is always
useless. But, we want to stress that this last perspective could not be the best strategy when
we want to study biochemical computer simulations
Gepasi, Scamp and METAMOD were constructed with biochemical restrictions in their
programming. Maybe the main assumption used in the computer programs cited, is the
theoretical restriction imposes by Metabolic Control Analysis (MCA). With this name is called
now a method that in another time was identify as a “theory”. The main concern of this method
is to get a good description of the pathway kinetics (Nielsen 1997). In particular, this method
permits to analyze how the control of fluxes and intermediate concentrations in a metabolic
pathway is conducted by different enzymes. An important aspect of this technique is that it is
assumed that the control of the flux is not due to a unique rate-limiting step. Instead of that, is
assumed that control flux is “spread” among the enzymes. From this context, we can suggest
that we have to consider theoretical restrictions when we try to evaluate computer simulations
in biochemistry.
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We have emphasized the role of in vivo- in vitro dichotomy when we analyzed
biochemical simulations and computer simulations of metabolic pathways11. But, this point can
be based on general considerations about the role of MCA. A major part of MCA history could
be understood as a pursuit of a better comprehension of in vivo conditions. Technical concepts
like elasticity or control coefficient, that are parts of MCA technique, can be considered a way to
describe properties that were not reduced to particular mechanism. As Mendes seems to imply,
to describe and characterize ‘systemic properties’, could be considered as a methodology for
describing and characterizing in vivo conditions (Mendes 1994). In this sense, it is evident that
this kind of computer simulations could be characterized by an ‘imitation’ relationship. This
imitation part could be seen not only by the simulation successful result, but also, as we have
seen, by the way in which the computer model is build. In those particular cases, a main
concern of biochemists is to get a good “imitation” of the dynamical aspects of the reaction.
Furthermore, to use some theoretical assumptions to construct the computational model is a
vehicle to achieve this purpose.
However, the same theoretical resources can be used to postulate a “disruption” or a
kind of abstraction from a particular target. We can see this aspect of biochemical simulations
from theoretical considerations that suppose the in vivo- in vitro dichotomy. Methodological
assumptions used in the construction of the computer programs cited, emphasize the behavior
of the whole pathway, considering the enzyme mechanism as a “black box”12. For example, it
could be suggested that, in the biochemical case mentioned above, is operating a mechanism
like cooperative feedback inhibition. A feedback inhibition is a very common mechanism that
can be understood as a transfer of flux control from an end-product in a step to the pathway of
11 Of course, the statements made here are only related with a particular kind of simulations of metabolic kinetics.
12 The perspective of MCA requires some knowledge about in vivo kinetics properties of enzymes. And most of the information
available now is from in vitro experiments. Cfr. Wang, L., I. Birol, et al. (2004)
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reactions – generally the first committed step in the pathway-. Nevertheless, this kind of
mechanism is practically ignored by the previous computer simulations, because of the
assumptions implicit in MCA. Those simulations take a perspective where the behavior of fluxes
and metabolite concentration are mainly “systemic properties” (Cornish-Bowden, Cardenas et
al. 2004). This particular aspect is based on using MCA technique. Moreover, this strategy is not
seen as part of the system limitations, but as contributing to the simulation task.
Additionally, there is another aspect that reveals a form of “disruption” in biochemical
computer simulations. In metabolic computer simulations, all reactions are treating as reversible
unless it is completely certain that a reaction have to be considered as reversible and this
assumption rest largely on MCA13. For example, when reactions like pyruvate transport are
taken as reversible, the distribution of flux control change radically from a step that not have
any control to the second most important step in the reaction (Cornish-Bowden and Cardenas
2003:514).
Conclusions
If the description of biochemical simulations presented in this paper is correct, then we
have arguments to redefine the intuitive and general idea of ‘simulation’ presented by
Hartmann. In particular, this idea of simulation has to be complemented by other concepts
beside imitation relationship. We propose that simulation idea, at least in biochemistry, use
relationships like ‘disruption’ or ‘isolation’.
There are some possible criticisms to the main thesis of this paper.
13 MCA made very different assumptions about irreversible or reversible reaction when it uses technical concepts like
“elasticity”. This is a property of an enzyme that consisted on the relationship of the variation of the rate regarding the
concentration of a metabolite. Cfr. Cornish-Bowden and Cárdenas (2000)
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It could be argued that “simulation” is an idea that describes only the “imitation” part of
in vivo- in vitro dichotomy. However, we want to follow the way in which biochemists use
“simulation” word, so the “extension” of simulation concept could be seen as an attempt to get
a simulation concept closer to scientific practices.
Another criticism can be expressed in the following way. Maybe the notion of simulation
proposed in this paper could be applied to biochemistry, but from this result, it is not evident
that this can be extended to others disciplines. Nevertheless, we do not claim that this concept
of simulation have to be extended to others disciplines – although it is a possibility that have to
be explored-. This partial objective is not against the main thesis of this paper. If we want to
get a better understanding of the scientific meaning of simulation concept, maybe we have to
consider partial characterizations.
There is even another possible criticism. “Imitation” seems to be understood in this
paper, as if this concept implies that the relationship between the simulation and the target has
to be seen in terms of “similarity”. But, from diverse sources this idea has been discredited. So,
the original “imitation” relationship do not exclude a “disruption” or “isolation” relationship. This
criticism supposed that the discussion about the role of “similarity” in scientific practices –
especially in model building- is closed. But, this discussion is far from being closed. However,
even in the case that we can interpret “imitation” in that way, we think that made explicit some
‘occult’ relationship could be a desirable objective.
Nevertheless, the maim criticism to the principal thesis of this paper is that the concept
of “isolation” or “disruption” could be seen as a common aspect of every model building.
According with this objection, when we build a model, we have to simplify some aspects. In this
sense, there is a “disruption” between the model and the “original”. Therefore, this idea of
simulation is only another aspect of a common and well-known process: model building. I think
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that this criticism made an important- and obvious- point: the close relationship between
simulation and model building. If biochemical simulations and computer simulations are both
models, then this similitude is not surprising. However, we try to show in this paper that
‘disruption’ relationship came mainly from in vivo- in vitro dichotomy. This could be seen from
the examples about perfusion and tissue slices technique in the section I, but also from the
cases of biochemical computer simulations. In particular, the technological process from
perfusion technique to tissue slices technique articulate a ‘disruption’ that stresses the general
simulation relationship. This way, smashed cells in an isolated vessel allows making better in
vivo approximations. The discussion about the possible relationship between cell integrity and
synthetic process only express the omnipresence of in vivo-in vitro dichotomy. In the case of
biochemical computer simulations, our main concern was to show evidence of the imbricate
association between computer and theoretical models. This point can be illustrated by the role
of MCA technique in computer restrictions and by the role of more empirical considerations
about channelling of dynamic complexes. We can maintain from this evidence, that ‘disruption’
relationship do not have to be reduced to a general process of model building, but instead this
kind of disruption have to be understood as a consequence of a biochemical model resting on in
vivo in vitro dichotomy.
At present, we can say that computer simulations are part of scientific practices. This
situation not only means the obvious statement that computers are in fact used by biochemist
but also that sometimes those computer simulations constitute actual biochemical practices.
Additionally, this state of affairs could be seen as another reason why is so difficult –or at least
“impractical”- to made a clear distinction between a computational and a “theoretical” model
when we analyze a particular example. With this statement, we do not suppose that it is
worthless to study “pure” computational aspect of the programs used in biochemistry. Instead,
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we want stress that we have to pay close attention to the way in which biochemists use
computer simulations. Maybe this is the main reason why disruption is not only part of model
building process, but is part of computer simulations in biochemistry. Trying to make a clear
and sharp distinction between computational and theoretical models could be result in a
‘denaturalization’ of actual biochemical practices and consequently there is a risk of missing the
particular biochemical context.
References
 Bugnon D, Potel G, Caillon J, Baron D, Drugeon HB, Feigel P, Kergueris MF, (1998),In
vivo simulation of human pharmacokinetics in the rabbit. Bull Math Biol. (3):545-67
 Cornish-Bowden and M. L. Cárdenas (2000) Irreversible Reactions in Metabolic
Simulations: how Reversible is Irreversible? in Animating the Cellular Map (ed. J.-H. S.
Hofmeyr, J. H. Rohwer and J. L. Snoep) Stellenbosch University Press, Stellenbosch, pp.
65–71.
 Cornish-Bowden, A. and J. H. Hofmeyr (2002). "The role of stoichiometric analysis in
studies of metabolism: an example." J Theor Biol 216(2): 179-91
 Cornish-Bowden, A. and M. L. Cardenas (2003). "Metabolic analysis in drug design." C R
Biol 326(5): 509-15.
 Cornish-Bowden, A. Eisenthal, R. (2000) Computer Simulation as a Tool for Studying
Metabolism and Drug Design, pp. 165–172 in (ed. Athel Cornish-Bowden and María Luz
Cárdenas),Technological and Medical Implications of Metabolic Control Analysis Kluwer
Academic Publishe Dordrecht, The Netherlands
 Cornish-Bowden, A., M. L. Cardenas, et al. (2004). "Understanding the parts in terms of
the whole." Biol Cell 96(9): 713-7.
 Fruton, J. (1973) The Emergence of Biochemistry, Science, Vol. 192, N 4237. 327-334.
 Hartmann, S. (1996), The world as a process: Simulations in the natural and social
sciences. In R. Hegselmann, U. Mueller, and K.G. Troitzsch, editors, Modelling and
simulation in the social sciences: From the philosophy of science point of view, vol. 23 of
Series A: Philosophy and methodology of the social sciences, pp. 77−100. Kluwer
Academic Publishers
 Haunschild, M. D., B. Freisleben, et al. (2005). "Investigating the dynamic behavior of
biochemical networks using model families." Bioinformatics 21(8): 1617-1625.
 Hofmeyr JH, van der Merwe KJ. (1986) METAMOD: software for steady-state modelling
and control analysis of metabolic pathways on the BBC microcomputer Comput Appl
Biosci. 1986 Dec;2(4):243-9.
 Holmes, F. (1992) The Right tools for the job : at work in twentieth-century life sciences
by Adele Clarke;  Joan H Fujimura
 Holmes, F., (1980), Hans Krebs and the discovery of the ornithine cycle Federation
Proceedings, 39, 216-225.
 Holmes, F., (1991) Hans Krebs: The formation of a Scientific Life 1900-1933 Vol. 1.
19
Oxford University Press, Oxford.
 Humphreys, P. (2004), Extending Ourselves: Computational Science, Empiricism, and
Scientific Method, Oxford University Press
 Kohler, R. (1973), The enzyme theory and the origins of biochemistry, Isis 64, 181-96.
 Leskovac, V. (2003). Comprehensive enzyme kinetics. New York, Kluwer
Academic/Plenum Pub.
 Mendes, P. (1993) GEPASI: A software package for modelling the dynamics, steady states
and control of biochemical and other systems. Comput. Applic. Biosci. 9, 563-571.
 Mendes, P. (1994) “Computer simulation of the dynamics of biochemical pathways”,
unpublished phD thesis, University of Wales, Aberystwyth
 Mendes, P., D. B. Kell, et al. (1996). "Why and when channelling can decrease pool size
at constant net flux in a simple dynamic channel." Biochim Biophys Acta 1289(2): 175-
86.
 Mendes, P., Kell, D.B. & Welch, G.R. (1995) Metabolic channelling in organized enzyme
systems: experiments and models. Advances in Molecular Cellular Biology 11, 1-19.
 Milani, M., A. Pesce, et al. (2003). "Substrate Channeling: Molecular Bases." Biochemistry
and Molecular Biology Education 31(4): 228-233.
 Nielsen, J.(1997) Metabolic control analysis of biochemical pathways based on a
thermokinetic description of reaction rates, Biochem J. 321(Pt 1): 133–138.
 Strand, R.; Fjelland, R.; Flatmark, T. (1996) In vivo interpretation of in vitro effect
studies. Acta Biotheoretica , 44, 1-21.
 Tomita, M., K. Hashimoto, et al. (1999). "E-CELL: software environment for whole-cell
simulation." Bioinformatics 15(1): 72-84.
